Mohammed L Ibrahim

5PUBLICATIONS
56CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|Jul 30, 2026
Design, synthesis, molecular docking and molecular dynamics simulations of pyrazolo[3,4-d]pyrimidine scaffolds as selective COX-2 and CDK2 kinase inhibitors with dual anti-inflammatory and anti-proliferative activities.

|Aug 27, 2024
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis.

Nana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis

|Jan 03, 2024
Histone Deacetylase Inhibitors Directly Modulate T Cell Gene Expression and Signaling and Promote Development of Effector-Exhausted T Cells in Murine Tumors.

Mohammed L Ibrahim, Hong Zheng, Margaret L Barlow

|Feb 09, 2023
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.

Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim

Pageof 1

Frequent Collaborators

3 joint publications

Amer A Beg

2 joint publications

Hong Zheng

2 joint publications

Xiaoqing Yu

2 joint publications

Dana Foresman